Why would anyone want to own MYL in the next year or so (unless you think they will get FDA approval for generic Copaxone)?
After the ‘spinversion’ (#msg-107440341), ABT will own 22% of MYL and plans to divest its MYL shares fairly quickly, which will put a lot of pressure on MYL’s share price.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.